Livingston, Journal of Cellular Biochemsitry, 64, pp. 19-26, 1997.* |
Taisho, 1 page, “KE-298,” Jan. 19, 1999. |
Takeshi Kamihara, The Japan Inflammation Academy, p. 75, “Antirheumatic Activites of KE-298, Having an Effect on IL-1,” Jul. 20 and 21, 1990 (with English Translation). |
V. Casini-Raggi, et al., Gastroenterology, vol. 109, pps. 812-818, “Anti-Inflammatory Effects of CGP 47969A, A Novel Inhibitor of Proinflammatory Cytokine Synthesis, in Rabbit Immune Colitis,” 1995. |
M. Tanaka, et al., Eur. J. Chem., vol. 31, pps. 187-198, “Hydroxyindole Derivatives as Inhibitors of IL-1 Generation. II. Synthesis and Pharmacological Activities of (E)-3-(7-Hydroxy-6-Methoxyindole-4-YL)-2-Methylpropenoic Acid Derivatives,” 1996. |
G. Ku, et al., Ctyokine, vol. 8, No. 5, pps. 377-386, “Interleukin-1β Converting Enzyme Inhibition Blocks Progression of Type II Collagen-Induced Arthritis in Mice,” May 1996. |
G. Nannini, et al., Eur. J. Med. Chem., vol. 14, No. 1, pps. 53-60, “Synthesis and Pharmacological Activtiy of Some 5, 6-Diphenyl-Pyridazines,” Jan.-Feb. 1979. |
J. Bondeson, et al., Biochemical Pharmacology, vol. 52, pps. 35-42,“Differntial Effects of Tenidap on the Zymosan- and Lipopolysaccharide-Induced Expression of mRNA For Proinflammatory Cytokines in Macrophages,” 1996. |